JP6355462B2 - 99mTc recovery device for medical diagnosis - Google Patents

99mTc recovery device for medical diagnosis Download PDF

Info

Publication number
JP6355462B2
JP6355462B2 JP2014143065A JP2014143065A JP6355462B2 JP 6355462 B2 JP6355462 B2 JP 6355462B2 JP 2014143065 A JP2014143065 A JP 2014143065A JP 2014143065 A JP2014143065 A JP 2014143065A JP 6355462 B2 JP6355462 B2 JP 6355462B2
Authority
JP
Japan
Prior art keywords
solution
concentration
activated carbon
built
high concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014143065A
Other languages
Japanese (ja)
Other versions
JP2016017935A (en
Inventor
克嘉 蓼沼
克嘉 蓼沼
幸治 石川
幸治 石川
明 津口
明 津口
剣一 加藤
剣一 加藤
睦 田仲
睦 田仲
優子 小松崎
優子 小松崎
祐未 鈴木
祐未 鈴木
きよ子 黒澤
きよ子 黒澤
英之 圷
英之 圷
純子 松井
純子 松井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Co Ltd
Original Assignee
Kaken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Co Ltd filed Critical Kaken Co Ltd
Priority to JP2014143065A priority Critical patent/JP6355462B2/en
Publication of JP2016017935A publication Critical patent/JP2016017935A/en
Application granted granted Critical
Publication of JP6355462B2 publication Critical patent/JP6355462B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、医療診断用99mTc回収装置に関する。 The present invention relates to a 99m Tc recovery device for medical diagnosis.

高濃度Mo(99Mo)溶液から各種の医療診断用99mTc回収装置が提案される。 Various types of 99m Tc recovery devices for medical diagnosis are proposed from a high-concentration Mo ( 99 Mo) solution.

特許文献1に記載された医療診断用99mTc回収装置は、本願の発明者等によって提案されたもので、新たに形成された高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着させ、99mTcを吸着させた後の高濃度Mo(99Mo)を再循環させ、再循環された高濃度Mo(99Mo)溶液について放射平衡状態を形成して99mTcを形成して、99mTcを含む高濃度Mo(99Mo)溶液を形成し、形成した99mTcを含む高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着することで99mTcを回収する医療診断用99mTc回収装置を内容としている。 The 99m Tc recovery device for medical diagnosis described in Patent Document 1 has been proposed by the inventors of the present application, and a newly formed high-concentration Mo ( 99 Mo) solution is applied to an adsorption column containing activated carbon. and liquid passing selectively adsorb 99m Tc high concentration Mo (99 Mo) solution to the activated carbon is recycled high density Mo (99 Mo) after adsorbing the 99m Tc, has been recycled to form a 99m Tc high concentration Mo (99 Mo) solution to form a radiation equilibrium for a high concentration Mo (99 Mo) to form a solution containing the 99m Tc, a high concentration Mo (99 containing the formed 99m Tc Mo) solution, for medical diagnosis recovering 99m Tc by and passed through the adsorption column that incorporates activated carbon selectively adsorbs 99m Tc of the high concentration Mo (99 Mo) solution to the activated carbon 9 the m Tc recovery system is the content.

特許第5427483号公報Japanese Patent No. 5427483

上述したように本願の発明者等によって医療診断用99mTc回収装置が提案された。このような医療診断用99mTc回収装置は、放射性の99mTc溶液を取り扱うものであるから99mTc回収に従事する操業者および環境に影響があってはならない。一方で、操業効率、操業簡便性が考慮されなければならない。 As described above, the inventors of the present application have proposed a 99m Tc recovery device for medical diagnosis. Such a 99m Tc recovery device for medical diagnosis handles radioactive 99m Tc solution, and therefore should not affect operators and environment engaged in 99m Tc recovery. On the other hand, operational efficiency and operational simplicity must be considered.

本発明は、かかる点に鑑み放射性の99mTc溶液を取り扱うに際して99mTc回収に従事する操業者および環境に影響がなく、操業効率、操業簡便性が考慮された医療診断用99mTc回収装置を提案することを目的とする。 In view of this point, the present invention proposes a 99m Tc recovery device for medical diagnosis that has no effect on the operator and environment engaged in 99m Tc recovery when handling radioactive 99m Tc solution, and that takes into consideration operational efficiency and operational simplicity. The purpose is to do.

本発明は、新たに形成された高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着させ、99mTcを吸着させた後の高濃度Mo(99Mo)を再循環させ、再循環された高濃度Mo(99Mo)溶液について放射平衡状態を形成して99mTcを形成して、99mTcを含む高濃度Mo(99Mo)溶液を形成し、形成した99mTcを含む高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着することで99mTcを回収する医療診断用99mTc回収装置において、
当該医療診断用99mTc回収装置に、新たに形成された高濃度Mo(99Mo)溶液を内蔵するMo(99Mo)溶液内蔵タンク、再循環された高濃度Mo(99Mo)溶液を内蔵して99mTcを製造する99mTc製造セルが収納されるものであって、
外部から遮断された外方空間部が内部に形成され溶液回収ポートを備えた外部遮蔽壁と、該外部遮蔽壁内に設けられ前記外方空間部から遮断された内方空間部を形成する内部遮蔽壁と、を備えて、
前記内方空内に前記Mo(99Mo)溶液内蔵タンクが収納され、前記外方空内に前記活性炭内蔵吸着カラムを備えた99mTc製造セルが収納され、
前記Mo(99Mo)溶液内蔵タンクと前記 99mTc製造セルとが接続され、前記活性炭内蔵吸着カラムで吸着された99mTcが前記方空間部に形成された前記溶液回収ポートから外部に取り出されるようにされたこと
を特徴とする医療診断用99mTc回収装置を提供する
In the present invention, a newly formed high concentration Mo ( 99 Mo) solution is passed through an adsorption column containing activated carbon, and 99 m Tc in the high concentration Mo ( 99 Mo) solution is selectively adsorbed on the activated carbon. is allowed, recirculated high concentration Mo (99 Mo) after adsorbing the 99m Tc, to form the 99m Tc to form a radiation equilibrium for the high concentration Mo (99 Mo) solution was recirculated, 99m A high-concentration Mo ( 99 Mo) solution containing Tc is formed, and the formed high-concentration Mo ( 99 Mo) solution containing 99m Tc is passed through an adsorption column containing activated carbon, and the high-concentration Mo ( 99 in 99 Mo) 99m Tc recovery device for medical diagnosis for recovering 99m Tc by selectively adsorbing 99m Tc in solution,
In the medical diagnostic 99m Tc collecting in the device, built newly formed high concentration Mo (99 Mo) solution incorporating a Mo (99 Mo) solution built tank, recirculated high concentration Mo (99 Mo) solution be one manufacturing cell 99m Tc to produce the 99m Tc is accommodated by,
Internal to form the outer shielding wall outer space which is cut off from the outside with a solution recovery port formed therein, the inner space portion cut off from the provided external shielding wall the outer space A shielding wall,
It said Hosora inter section the Mo (99 Mo) solution built tank within the housing, producing cells 99m Tc with the activated carbon built adsorption column in the outer Hosora inter unit is housed,
The Mo (99 Mo) a solution built tank and producing cells of the 99m Tc is connected, 99m Tc adsorbed by the activated carbon built-adsorption column is taken out from the solution recovery port formed in the outer space A 99m Tc recovery device for medical diagnosis is provided .

本発明は、上述された医療診断用99mTc回収装置において、前記方空内に99mTcの製造セルをメンテナンスするためのメンテナンスエリアが形成されることを特徴とする医療診断用99mTc回収装置を提供する The present invention, in the above described medical diagnostic 99m Tc recovery apparatus, the outer wherein the maintenance area for maintenance of the production cell of 99m Tc is formed in the space portion Hosora medical diagnostic 99m Tc A collection device is provided .

本発明によれば、内方空間部内にMo(99Mo)溶液内蔵タンクが収納され、外方空間部内に活性炭内蔵吸着カラムを備えた99mTc製造セルが収納され、Mo(99Mo)溶液内蔵タンクと99mTc製造セルとが接続され、該活性炭内蔵吸着カラムで回収された99mTcが外部に取り出されるようにされた。Mo(99Mo)溶液内蔵タンク内のMo(99Mo)溶液は新たに形成されたものであるので比較的に放射能が強く、このため内方空間部内に収納されて十分に放射能の影響が遮断され、99mTcを製造セル内の製造99mTcは、比較的に放射能が弱く、外方空間部内に収納することで十分に放射能の影響が遮断され、この外方空間部内に、活性炭内蔵吸着カラムに接続されて配置されるものであるので、回収された 99m Tc溶液を外部への取り出しに便利であり、操業効率、操業簡便性が考慮された医療診断用99mTc回収装置とすることができる。 According to the present invention, it is accommodated Mo (99 Mo) solution built tank inward space, producing cells of 99m Tc with activated carbon built-adsorption column is housed in the outer space portions, Mo (99 Mo ) and producing cell solution built tank and 99m Tc is connected, it recovered 99m Tc in the activated carbon built-adsorption column is to be taken outside. Since the Mo ( 99 Mo) solution in the Mo ( 99 Mo) solution built-in tank is newly formed, it has a relatively strong radioactivity. Therefore, the Mo ( 99 Mo) solution is stored in the inner space and is sufficiently affected by the radioactivity. There is blocked, prepared 99m Tc in the production of 99m Tc cells, weak radioactive relatively, the influence of sufficiently radioactivity by accommodating outward space portion is cut off, to the outer space portions 99m Tc recovery device for medical diagnosis that is convenient for taking out the recovered 99m Tc solution to the outside and is considered to be operational efficiency and operational convenience It can be.

本発明の実施例の形態を示す図。The figure which shows the form of the Example of this invention. 99mTc抽出製造装置51の例を示す図。 The figure which shows the example of 99m Tc extraction manufacturing apparatus 51. FIG. 99mTc抽出ステップを示す図。 The figure which shows 99m Tc extraction step.

以下、本発明の形態を図面に基づいて説明する。   Hereinafter, embodiments of the present invention will be described with reference to the drawings.

図1は、本発明の実施例の形態を示す図である。   FIG. 1 is a diagram showing an embodiment of the present invention.

医療診断用99mTc回収装置100は、新たに形成された高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着させ、99mTcを吸着させた後の高濃度Mo(99Mo)を再循環させ、再循環された高濃度Mo(99Mo)溶液について放射平衡状態を形成して99mTcを形成して、99mTcを含む高濃度Mo(99Mo)溶液を形成し、形成した99mTcを含む高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着することで99mTcを回収する装置として構成される。 The 99m Tc recovery device 100 for medical diagnosis passes a newly formed high-concentration Mo ( 99 Mo) solution through an adsorption column containing activated carbon, and 99 m in the high-concentration Mo ( 99 Mo) solution through the activated carbon. Tc selectively adsorb, recirculates high concentration Mo (99 Mo) after adsorbing the 99m Tc, recycled high concentration Mo (99 Mo) solution to form a radiation equilibrium for 99m Tc forming a high concentration Mo (99 Mo) to form a solution, high concentration Mo (99 Mo) solution containing the formed 99m Tc, the activated carbon was passed through the adsorption column having a built-in active carbon containing 99m Tc the high concentration Mo configured as a device for collecting the 99m Tc in (99 Mo) the 99m Tc in solution selectively be adsorbed.

図1において、医療診断用99mTc回収装置100は、一体箱状形態に構成され、外側に配置された外側遮蔽壁1および内側に配置された内側遮蔽壁2を備える。外側遮蔽壁1によって、内部にメンテナンスエリア3が形成される。メンテナンスエリア3は、その中央部に設けられた上下室分離用の分離体6によって上下室に分けられる。ここでは、外方遮蔽壁1と内方遮蔽壁2で形成された上方のメンテナンセエリアを上部外側の外方空間部4Aと呼び、下方のメンテナンスエリアを下部外側の外方空間部4Bと呼ぶ。内方遮蔽壁2で形成された内方空間部5の上方の室を下部外側の内方空間部5Aと呼び、下方の室を下部内側の内方空間部5Bと呼ぶ。内側遮蔽壁2の下側には、外部開放の下部室7が形成され、電源制御系8が配置される。 In FIG. 1, a 99m Tc recovery device 100 for medical diagnosis is configured in an integral box shape, and includes an outer shielding wall 1 arranged on the outer side and an inner shielding wall 2 arranged on the inner side. A maintenance area 3 is formed inside by the outer shielding wall 1. The maintenance area 3 is divided into upper and lower chambers by a separating body 6 for separating upper and lower chambers provided in the central portion thereof. Here, call outwardly maintenance Nan cell area of the upper formed by the shielding wall 1 and the inner shielding wall 2 and the upper outer of the outer space 4A, referred to as maintenance area below the lower outer of the outer space 4B . The chamber above the inner space portion 5 formed by the inner shielding wall 2 is referred to as a lower outer space 5A, and the lower chamber is referred to as a lower inner space 5B . A lower chamber 7 that is open to the outside is formed below the inner shielding wall 2, and a power supply control system 8 is disposed.

上部外側の外方空間部4Aおよび下部外側の外方空間部4Bには、換気系9が接続され、排気がなされる。 A ventilation system 9 is connected to the outer space portion 4A on the upper outer side and the outer space portion 4B on the lower outer side , and exhaust is performed.

上部外側の外方空間部4Aおよび下部外側の外方空間部4Bには、レール10が施設される。本例の場合、2組のレール配置としてある。 Rails 10 are provided in the outer space portion 4A on the upper outer side and the outer space portion 4B on the lower outer side . In this example, there are two sets of rail arrangements.

上部外側の外方空間部4Aの上方の外側遮蔽壁1には扉11、上下室分離用の分離体6には外側に扉12、内側に扉13が設けられ、下部外側の外方空間部4Bの側方の外側遮蔽壁1にはPbガラスが配設され、その外側にマニピュレータ15が敷設される。下部外側空間部4Bの下方の外側遮蔽壁1には一対の99mTc溶液回収ポート16が形成されている。 Door 11 to the outer shield wall 1 above the upper outer of the outer space 4A, the upper and lower compartment door 12 outwardly in separator 6 for separation, the door 13 is provided inside the lower outer of the outer space Pb glass is disposed on the outer shielding wall 1 on the side of 4B, and a manipulator 15 is laid on the outside thereof. A pair of 99m Tc solution recovery ports 16 are formed in the outer shielding wall 1 below the lower outer space 4B.

下部内側の内方空間部5Bの内部に、Mo(99Mo)溶液内蔵タンクであるところの調整タンク21および2つのMo(99Mo)溶液タンク22,23が設置される。下部外側の外方空間部4Bに99mTcを製造セル24,25が設置される。両者は、接続される。99mTc製造セル24,25は、活性炭内蔵吸着カラムを備える。 An adjustment tank 21 that is a Mo ( 99 Mo) solution built-in tank and two Mo ( 99 Mo) solution tanks 22 and 23 are installed in the inner space 5B inside the lower part. Manufacturing cells 24 and 25 of 99m Tc are installed in the outer space 4B outside the lower part. Both are connected. Producing cells 24 and 25 of the 99m Tc has a charcoal internal adsorption column.

99mTc製造セル24,25には、それぞれ製造された99mTc溶液を排出する一対の排出路26が設けられ、99mTc溶液回収ポート16に接続される。 The manufacturing cell 24, 25 of the 99m Tc, the pair of discharge path 26 is provided for discharging the 99m Tc solution prepared respectively, are connected to the 99m Tc solution recovery port 16.

99mTc製造セル24,25は、それぞれレール10上を上部外側の外方空間部4Aに引き出されて定期面メンテナンス27による維持管理がなされる。 99m Tc manufacturing cell 24 and 25, the upper rail 10 respectively is drawn to the upper outer side of the external space portion 4A maintenance through periodic surface maintenance 27 is made.

以上のようにして、内部にメンテナンスエリアを形成するように形成された外部遮蔽壁1と、メンテナンスエリア3内に内方空間部を形成するように、メンテナンスエリア3内に形成された内部遮蔽壁2と、を備えて、メンテナンスエリア3内であって、外部遮蔽壁1と内部遮蔽壁2との間に上部外側の外方空間部4Aおよび下部外側の外方空間部4Bからなる外方空間部が形成される。 As described above, the external shielding wall 1 formed so as to form the maintenance area therein, and the internal shielding wall formed in the maintenance area 3 so as to form the inner space portion in the maintenance area 3. provided with 2, and a maintenance area within 3, the outer space of the upper outer of the outer space 4A and lower outer of the outer space 4B between the outer shielding wall 1 and the inner shielding wall 2 Part 4 is formed.

また、内方空間部5内にMo(99Mo)溶液内蔵タンクを形成する調整タンク21、Mo(99Mo)溶液タンク22,23が収納され、外方空間部4内に活性炭内蔵吸着カラムを備えた99mTc製造セル24,25が収納される。 Further, housed adjustment tank 21, Mo (99 Mo) solution tank 22 to form a Mo (99 Mo) solution built tank inwardly space portion 5, an activated carbon built-adsorption column in the external space portion 4 99m Tc manufacturing cell 24, 25 with is housed.

また、Mo(99Mo)溶液内蔵タンク22,2399mTc製造セル24、25とが接続され、該活性炭内蔵吸着カラムで回収された99mTcが 99m Tc溶液回収ポート16から外部に取り出される。 Further, Mo (99 Mo) and generating cell 24, 25 of a solution built tanks 22, 23 and 99m Tc is connected, recovered 99m Tc in the activated carbon built-adsorption column is taken out from the 99m Tc solution recovery port 16 .

図2は、内方空間部5内にMo(99Mo)溶液内蔵タンクを形成する調整タンク21、Mo(99Mo)溶液タンク22,23、外方空間部4内に活性炭内蔵吸着カラムを備えた99mTc製造セル24,25の機能を示す。図1と図2の対比において、調整タンク21が制御タンク54に該当し、Mo(99Mo)溶液タンク22,23がMo容器52,53に該当する。99mTc製造セル24,25は、Tc濃縮精製回収系66を包含する。以下、図2の構成について説明する。 FIG. 2 shows an adjustment tank 21 forming a Mo ( 99 Mo) solution built-in tank in the inner space 5 , Mo ( 99 Mo) solution tanks 22 and 23, and an activated carbon built-in adsorption column in the outer space 4 . The functions of the 99m Tc manufacturing cells 24 and 25 are shown. In the comparison between FIG. 1 and FIG. 2, the adjustment tank 21 corresponds to the control tank 54, and the Mo ( 99 Mo) solution tanks 22 and 23 correspond to the Mo containers 52 and 53. Producing cells 24 and 25 of the 99m Tc encompass Tc concentration and purification recovery system 66. Hereinafter, the configuration of FIG. 2 will be described.

図2は、99mTc抽出装置26を構成する99mTc抽出製造装置51の例を示す図である。図3は、高純度99mTc溶液の抽出による製造ステップをS1〜S7のステップで示す図である。 FIG. 2 is a diagram showing an example of a 99m Tc extraction and production apparatus 51 that constitutes the 99m Tc extraction apparatus 26. FIG. 3 is a diagram showing the manufacturing steps by extraction of a high-purity 99m Tc solution in steps S1 to S7.

図2、図3において、99mTc抽出製造装置51は99Mo及び99mTcから放出される放射線を遮蔽するホットセル内に設置される。99mTc抽出製造装置51は、Mo容器(1)52、Mo容器(2)53および制御タンク54を備える。複数のMo容器を備えるようにしてもよい。Mo容器(1)52およびMo容器(2)55には中性子照射されて99Moが生成し含まれるMoOをアルカリ(NaOH)溶液で溶解して生成されるNa 99MoO溶液が供給される。すなわち、放射性医薬品原料としての放射性核種99Moを含んだMo溶液がMo容器(1)52およびMo容器(2)53に供給される。99MoOがアルカリ溶液で溶解されると、図に示すようにpH中性のNa 99MoO溶液が形成される。 2 and 3, the 99m Tc extraction and production apparatus 51 is installed in a hot cell that shields radiation emitted from 99 Mo and 99m Tc. The 99m Tc extraction and production apparatus 51 includes a Mo container (1) 52, a Mo container (2) 53, and a control tank. A plurality of Mo containers may be provided. The Mo container (1) 52 and the Mo container (2) 55 are supplied with a Na 2 99 MoO 4 solution generated by neutron irradiation to generate 99 Mo and dissolve the contained MoO 3 with an alkali (NaOH) solution. The That is, the Mo solution containing the radionuclide 99 Mo as a radiopharmaceutical raw material is supplied to the Mo container (1) 52 and the Mo container (2) 53. When 99 MoO 3 is dissolved in an alkaline solution, a pH neutral Na 2 99 MoO 4 solution is formed as shown in the figure.

生成に際して、放射性99Moを含むMo溶液は例えば2L中に500gのMoを含む高い濃度のMo溶液とされる。以下、この溶液を高濃度Mo溶液という。ここで、高濃度とは、例えば1回500Ci程度の必要量の99mTcを得るために、前述の2L中に500gのMoを含む高濃度Mo溶液が必要となるための濃度ということである。 At the time of production, the Mo solution containing radioactive 99 Mo is, for example, a high concentration Mo solution containing 500 g of Mo in 2 L. Hereinafter, this solution is referred to as a high concentration Mo solution. Here, the high concentration is, for example, a concentration at which a high concentration Mo solution containing 500 g of Mo in 2 L described above is required to obtain a necessary amount of 99m Tc of about 500 Ci at a time.

Mo容器(1)52およびMo容器(2)53の底部には、それぞれ三方弁55、56を備えた配管57、58が設けてあり、Mo容器(1)52およびMo容器(2)53は3方弁55、56および配管57、58更に他の配管59、60を介して制御タンク54の底部に接続されている。配管57、58の終端に3方弁63が備えられる。制御タンク54は液面調整機構としての機能を備える。制御タンク54の底部は、さらに配管64、配管64に設けた3方弁65を介してTc濃縮精製回収系66の一端(図では上面)に接続される。このTc濃縮精製回収系66は後述するように、活性炭を内蔵した吸着カラムを備える。   Pipings 57 and 58 having three-way valves 55 and 56 are respectively provided at the bottoms of the Mo container (1) 52 and the Mo container (2) 53, and the Mo container (1) 52 and the Mo container (2) 53 are Three-way valves 55 and 56 and pipes 57 and 58 are connected to the bottom of the control tank 54 via other pipes 59 and 60. A three-way valve 63 is provided at the end of the pipes 57 and 58. The control tank 54 has a function as a liquid level adjustment mechanism. The bottom of the control tank 54 is further connected to one end (upper surface in the figure) of the Tc concentration purification / recovery system 66 via a pipe 64 and a three-way valve 65 provided in the pipe 64. As will be described later, the Tc concentration purification / recovery system 66 includes an adsorption column containing activated carbon.

Tc濃縮精製回収系66の他端(図では下端)には、配管67およびこれに設けられた3方弁68が設けられ、配管57および配管58の終端に設けた3方弁63に接続される。Mo容器(1)52およびMo容器(2)53で、高濃度Mo溶液中で99Moの娘核種である99mTcが生成されて、放射性核種99Moおよび99mTcを含む高濃度Mo溶液が形成される。99Moを含む新しい高濃度Mo溶液は交互に、例えば隔週毎にいずれかのMo容器(1)52およびMo容器(2)53に入れ替え供給される。 The other end (lower end in the figure) of the Tc concentration purification system 66 is provided with a pipe 67 and a three-way valve 68 provided on the pipe 67 and connected to a three-way valve 63 provided at the end of the pipe 57 and the pipe 58. The In the Mo container (1) 52 and the Mo container (2) 53, 99m Tc which is a daughter nuclide of 99 Mo is generated in the high concentration Mo solution, and a high concentration Mo solution containing the radionuclides 99 Mo and 99m Tc is formed. Is done. A new high-concentration Mo solution containing 99 Mo is alternately supplied to, for example, every Mo container (1) 52 and Mo container (2) 53 every two weeks.

弱いエネルギーのγ線(放射線)を放出するテクネチウム99(99mTc)はSPECTのような医学診断に使用されるが、半減期が6時間であるため1日で16分の1にまでその放射能量は減少してしまう。これを補うために99mTcの親核種である99Moを保有して、そのベータ・マイナス崩壊を起こして生まれる99mTcを分離・利用する。このように親核種と娘核種の放射平衡関係を利用して娘核種を得る方法がミルキングと呼ばれる。 Technetium 99 ( 99m Tc), which emits weak energy gamma rays (radiation), is used for medical diagnosis such as SPECT, but its half-life is 6 hours, so its radioactivity is reduced to 1/16 of a day. Will decrease. It holds a 99 Mo, which is the parent nuclide of 99m Tc in order to compensate for this, to separate and use the 99m Tc born causing the beta-minus decay. A method for obtaining a daughter nuclide using the radiation equilibrium relationship between the parent nuclide and the daughter nuclide is called milking.

ここでは、このように親核種と娘核種の放射平衡関係を利用して娘核種を得る方法をミルキングと称する。また、このミルキングを行うことをミルキング処理と称し、娘核種を含む溶液をミルキング溶液と称する。従って、ここで99Moを含む高濃度Mo溶液とは、上述のように、放射平衡関係を利用して必要量の99mTcを得るための99Moを含む溶液ということである。 Here, the method for obtaining the daughter nuclide by using the radiation equilibrium relationship between the parent nuclide and the daughter nuclide is called milking. Moreover, performing this milking is called a milking process, and the solution containing a daughter nuclide is called a milking solution. Thus, where a high concentration Mo solution containing 99 Mo, as described above, is that a solution containing 99 Mo for obtaining 99m Tc required amount by utilizing radiation equilibrium.

高濃度99Mo溶液は、配管57ならびに配管58、三方弁63、配管67を介してTc濃縮精製回収系66の下部から活性炭カラムを内蔵するTc濃縮精製回収系66へ導入される。Tc濃縮精製回収系66は、吸着カラムを備え、吸着カラムに活性炭が内蔵されているので、この活性炭に必要量の99mTcを含む高濃度99Mo溶液を通液することによって、99mTcを選択的に吸着させることができる。この工程で99mTcの精製、濃縮がなされる。ここで、高濃度Mo溶液中のMo量(ここでは、500g)に対する99Mo量と99mTc量との関係を示せば次のようである。 The high-concentration 99 Mo solution is introduced into the Tc concentration purification / recovery system 66 containing the activated carbon column from the lower part of the Tc concentration purification / recovery system 66 through the pipe 57, the pipe 58, the three-way valve 63, and the pipe 67. The Tc concentration purification / recovery system 66 includes an adsorption column, and activated carbon is incorporated in the adsorption column, so 99m Tc is selected by passing a high concentration 99 Mo solution containing a necessary amount of 99m Tc through the activated carbon. Can be adsorbed. In this step, 99m Tc is purified and concentrated. Here, the relationship between the 99 Mo amount and the 99m Tc amount with respect to the Mo amount (here, 500 g) in the high-concentration Mo solution is as follows.

99Moの半減期:65.94h,99mTcの半減期:6.01h
500Ci99Mo量=1.04mg(500gMoに対し1/50万)
500Ci99mTc量=0.095mg(500gMoに対し1/500万)
99Mo 5×10Bq以下の場合、500gMoに対し6×10−15以下
99mTc 6×10Bq以下の場合、500gMoに対し6×10−16以下
このように、高濃度Mo溶液に極わずかに99mTcが存在する場合にあっても活性炭によって吸着させることができる。
99 Mo half-life: 65.94 h, 99m Tc half-life: 6.01 h
500 Ci 99 Mo amount = 1.04 mg (1 / 500,000 for 500 g Mo)
500 Ci 99m Tc amount = 0.095 mg (1/5 million for 500 g Mo)
In the case of 99 Mo 5 × 10 4 Bq or less, 6 × 10 −15 or less with respect to 500 g Mo
In the case of 99m Tc 6 × 10 4 Bq or less, 6 × 10 −16 or less with respect to 500 g Mo. Thus, even when 99m Tc is present in a very high concentration Mo solution, it can be adsorbed by activated carbon.

Tc濃縮精製回収系66で吸着されない99Moを含む大量のMoは、三方弁65および配管64を介して、制御タンク54に、更にはMo容器(1)52あるいはMo容器(2)53のいずれかに戻される。毎日99mTc吸着工程が実施され、99mTcが回収されたMo溶液は元のMo容器(52あるいは53のいずれか)に戻される。この工程の後、Tc濃縮精製回収系66に吸着回収された99mTcは脱着工程へと移行される。 A large amount of Mo containing 99 Mo that is not adsorbed by the Tc concentration purification / recovery system 66 passes through the three-way valve 65 and the pipe 64 to the control tank 54, and further to either the Mo container (1) 52 or the Mo container (2) 53. It will be returned. A 99m Tc adsorption step is performed every day, and the Mo solution from which 99m Tc has been recovered is returned to the original Mo container (either 52 or 53). After this step, 99m Tc adsorbed and recovered by the Tc concentration purification recovery system 66 is transferred to a desorption step.

このように、放射性核種99Moを含む高濃度Mo溶液を、中性子照射したMo化合物(MoO)を直接的にアルカリ溶液で溶解することで99Moを含む高濃度Mo溶液を形成し、複数のMo容器に供給し、これらの複数のMo容器に貯められた高濃度99Mo溶液を交互に前記活性炭を収納する吸着カラムに通液してTcを吸着濃縮し、しかる後に溶出精製回収することを行う。 In this way, a high concentration Mo solution containing the radionuclide 99 Mo is dissolved in the neutron-irradiated Mo compound (MoO 3 ) directly in an alkaline solution to form a high concentration Mo solution containing 99 Mo. A high concentration 99 Mo solution stored in a plurality of Mo containers is alternately passed through an adsorption column containing the activated carbon, and Tc is adsorbed and concentrated. Do.

三方弁68には配管70、三方弁71を介して外部の供給系22が接続され、この供給系72からはTc濃縮精製回収系66(活性炭カラム)に残存する99Moの脱着のための洗浄液およびTc溶出液他が供給され、これらの溶液はTc濃縮精製回収系66に導入される。 An external supply system 22 is connected to the three-way valve 68 via a pipe 70 and a three-way valve 71. From this supply system 72, a cleaning solution for desorbing 99 Mo remaining in the Tc concentration purification / recovery system 66 (activated carbon column). And Tc eluate and the like are supplied, and these solutions are introduced into the Tc concentration purification collection system 66.

まず、脱着工程において99Mo脱着剤が供給系72から導入され、99Moが脱着され、この溶液は洗浄廃液82に導入される。次いで、99Mo脱着工程が止められ、Tc脱着剤が供給系72から導入され、活性炭に吸着されたTcが脱着されるTc脱着工程へと移行する。 First, in the desorption process, 99 Mo desorbent is introduced from the supply system 72, 99 Mo is desorbed, and this solution is introduced into the cleaning waste liquid 82. Next, the 99 Mo desorption process is stopped, a Tc desorption agent is introduced from the supply system 72, and the process proceeds to a Tc desorption process in which Tc adsorbed on the activated carbon is desorbed.

Tc濃縮精製回収系66は、三方弁65を介して、配管73、これに設けた3方弁74を介して液性調整系75に接続されている。脱着したTcは脱着剤と共に液性調整系75に導入される。この液性調整系で液性調整用試薬84が加えられ、液性調整され、更に配管76を介して2次精製系77に、更に配管78を介してTc回収装置79に接続され、99mTc溶出液として回収される。 The Tc concentration purification / recovery system 66 is connected to a liquidity adjustment system 75 via a three-way valve 65 and a pipe 73 and a three-way valve 74 provided thereon. The desorbed Tc is introduced into the liquid property adjusting system 75 together with the desorbing agent. In this liquid adjustment system, a liquid adjustment reagent 84 is added to adjust the liquidity. Further, the liquid adjustment reagent 84 is further connected to the secondary purification system 77 via the pipe 76 and further connected to the Tc recovery device 79 via the pipe 78. 99m Tc Collected as eluate.

このシステムには、図2に示すように、99Mo使用後廃液系80、81および洗浄廃液系82が設けられ、各系統は制御系83によって適宜制御されるようになっている。 As shown in FIG. 2, this system is provided with 99 Mo waste liquid systems 80 and 81 and a cleaning waste liquid system 82, and each system is appropriately controlled by a control system 83.

以上のようにして、放射性医薬品原料としての放射性核種99Moを含む高濃度Mo溶液を形成し、99Moの娘核種である99mTcを生成して放射性核種99Moおよび99mTcを含む高濃度99Mo溶液を形成し、
形成した当該高濃度Mo溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度99Mo溶液中の99mTcを選択的に吸着させ、99mTcを選択的に吸着させた後の高濃度99Moを再循環系に導出させ、活性炭に残留する99MoをMo脱着剤によって脱着除去を行い、活性炭に残留した微量の99mTcを活性炭から脱着剤による99mTcの脱着処理を行って、99mTcを回収し、
回収した99mTc中に僅かに残留する99Moをアルミナカラム法によって除去する二次精製を行い、
99mTcが吸着処理され、再循環系に導出され、回収された前記高濃度99Mo溶液から、
再び放射平衡状態まで99mTcを生成して、放射性核種99Moおよび99mTcを含む高濃度99Mo溶液を再び形成し、形成した当該高濃度99Mo溶液を、再循環して活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度99Mo溶液中の99mTcを選択的に吸着させることを特徴とする放射性医薬品原料としての99mTcの高濃縮および溶出精製回収方法が形成される。
As described above, a high-concentration Mo solution containing radionuclide 99 Mo as a radiopharmaceutical raw material is formed, 99m Tc which is a daughter nuclide of 99 Mo is generated, and high concentration 99 containing radionuclide 99 Mo and 99m Tc is formed. Forming a Mo solution;
Formed was the high concentration 9 Mo solution was passed through the adsorption column that incorporates activated carbon is selectively adsorb 99m Tc of the high density 99 Mo solution to the activated carbon and selectively adsorbing the 99m Tc is derived recirculation system at a high concentration 99 Mo after the 99 Mo remaining in the activated carbon subjected to desorption removed by Mo desorbent, the desorption process of the 99m Tc by desorbing agent 99m Tc traces remaining on the activated carbon activated carbon Go and collect 99m Tc,
Perform secondary purification to remove 99 Mo slightly remaining in the recovered 99m Tc by the alumina column method,
99m Tc is adsorbed, extracted into the recirculation system, and recovered from the highly concentrated 99 Mo solution.
99m Tc is generated again to a radiation equilibrium state, a high concentration 99 Mo solution containing radionuclides 99 Mo and 99m Tc is formed again, and the formed high concentration 99 Mo solution is recirculated to adsorb activated carbon. high concentration and elution purification and recovery method of 99m Tc as a radiopharmaceutical material was passed through the column, characterized in that selectively adsorbs 99m Tc of the high density 99 Mo solution to the activated carbon is formed.

本実施例によれば、内方空間部内にMo(99Mo)溶液内蔵タンクが収納され、外方空間部内に活性炭内蔵吸着カラムを備えた99mTc製造セルが収納され、Mo(99Mo)溶液内蔵タンクと99mTc製造セルとが接続され、該活性炭内蔵吸着カラムで回収された99mTcが外部に取り出されるようにされた。Mo(99Mo)溶液内蔵タンク内のMo(99Mo)溶液は新たに形成されたものであるので比較的に放射能が強く、このため内方空間部内に収納されて十分に放射能の影響が遮断され、99mTc製造セル内の製造99mTcは、比較的に放射能が弱く、外方空間部内に収納することで十分に放射能の影響が遮断され、しかもこの外方空間部内に、活性炭内蔵吸着カラムに接続されて配置されるものであるので99mTcの外部への取り出しに便利であり、操業効率、操業簡便性が考慮された医療診断用99mTc回収装置とすることができる。 According to this embodiment, is accommodated Mo (99 Mo) solution built tank inward space, producing cells of 99m Tc with activated carbon built-adsorption column is housed in the outer space portions, Mo (99 Mo) and producing cell solution built tank and 99m Tc is connected, it recovered 99m Tc in the activated carbon built-adsorption column is to be taken outside. Since the Mo ( 99 Mo) solution in the Mo ( 99 Mo) solution built-in tank is newly formed, it has a relatively strong radioactivity. Therefore, the Mo ( 99 Mo) solution is stored in the inner space and is sufficiently affected by the radioactivity. There is blocked, prepared 99m Tc in the manufacturing cell of 99m Tc is weak radioactive relatively, the influence of sufficiently radioactivity by accommodating outward space portion is blocked, yet in the outer space portions Since it is connected to an adsorption column with built-in activated carbon, it is convenient for taking out 99m Tc to the outside, and it can be a 99m Tc recovery device for medical diagnosis in consideration of operational efficiency and operational convenience. .

1…外側遮蔽壁、2…内側遮蔽壁、3…メンテナンスエリア、4…外空間部、4A…上部外側の外方空間部、4B…下部外側の外方空間部、5…内空間部、5A…上部内側の内部空間部、5B…下部内側の内部空間部、6…上下室分離用の分離体、21…調整タンク、22,23…Mo(99Mo)溶液タンク、24,25…99mTc製造セル、100…医療診断用99mTc回収装置。

1 ... outer shielding wall, 2 ... inner shielding wall, 3 ... maintenance area, 4 ... outer space, the external space of 4A ... upper outer, 4B ... outer space of the lower outer, 5 ... inner side space , the internal space of 5A ... upper inner, 5B ... inner space of the lower inner, 6 ... upper and lower chambers separator for separation, 21 ... adjustment tank, 22,23 ... Mo (99 Mo) solution tank, 24, 25 ... production cell of 99m Tc, 100 ... medical diagnostic 99m Tc recovery system.

Claims (2)

新たに形成された高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着させ、99mTcを吸着させた後の高濃度Mo(99Mo)を再循環させ、再循環された高濃度Mo(99Mo)溶液について放射平衡状態を形成して99mTcを形成して、99mTcを含む高濃度Mo(99Mo)溶液を形成し、形成した99mTcを含む高濃度Mo(99Mo)溶液を、活性炭を内蔵する吸着カラムへ通液して該活性炭に当該高濃度Mo(99Mo)溶液中の99mTcを選択的に吸着することで99mTcを回収する医療診断用99mTc回収装置において、
当該医療診断用99mTc回収装置に、新たに形成された高濃度Mo(99Mo)溶液を内蔵するMo(99Mo)溶液内蔵タンク、再循環された高濃度Mo(99Mo)溶液を内蔵して99mTcを製造する99mTc製造セルが収納されるものであって、
外部から遮断された外方空間部が内部に形成され溶液回収ポートを備えた外部遮蔽壁と、該外部遮蔽壁内に設けられ前記外方空間部から遮断された内方空間部を形成する内部遮蔽壁と、を備えて、
前記内方空内に前記Mo(99Mo)溶液内蔵タンクが収納され、前記外方空内に前記活性炭内蔵吸着カラムを備えた99mTc製造セルが収納され、
前記Mo(99Mo)溶液内蔵タンクと前記 99mTc製造セルとが接続され、前記活性炭内蔵吸着カラムで吸着され99mTcが前記方空間部に形成された前記溶液回収ポートから外部に取り出されるようにされたこと
を特徴とする医療診断用99mTc回収装置。
The newly formed high concentration Mo (99 Mo) solution was passed through the adsorption column that incorporates activated carbon is selectively adsorb 99m Tc high concentration Mo (99 Mo) solution to the activated carbon, 99m Tc The high-concentration Mo ( 99 Mo) after adsorbing is recycled, and a radiative equilibrium state is formed for the recirculated high-concentration Mo ( 99 Mo) solution to form 99m Tc, and the high concentration containing 99m Tc A high-concentration Mo ( 99 Mo) solution is formed, and the high-concentration Mo ( 99 Mo) solution containing 99m Tc formed is passed through an adsorption column containing activated carbon, and the high-concentration Mo ( 99 Mo) solution is passed through the activated carbon. in 99m Tc recovery apparatus for medical diagnosis for recovering 99m Tc by selectively adsorbing 99m Tc in,
In the medical diagnostic 99m Tc collecting in the device, built newly formed high concentration Mo (99 Mo) solution incorporating a Mo (99 Mo) solution built tank, recirculated high concentration Mo (99 Mo) solution be one manufacturing cell 99m Tc to produce the 99m Tc is accommodated by,
Internal to form the outer shielding wall outer space which is cut off from the outside with a solution recovery port formed therein, the inner space portion cut off from the provided external shielding wall the outer space A shielding wall,
It said Hosora inter section the Mo (99 Mo) solution built tank within the housing, producing cells 99m Tc with the activated carbon built adsorption column in the outer Hosora inter unit is housed,
The Mo (99 Mo) a solution built tank and producing cells of the 99m Tc is connected, is adsorbed by the activated carbon built-adsorption column 99m Tc is extracted out from the solution recovery port formed in the outer space 99m Tc recovery device for medical diagnosis, characterized in that it is configured as described above.
請求項1に記載された医療診断用99mTc回収装置において、前記方空内に99mTcの製造セルをメンテナンスするためのメンテナンスエリアが形成されることを特徴とする医療診断用99mTc回収装置。 In medical diagnostic 99m Tc recovery device according to claim 1, wherein the outer characterized in that the maintenance area for maintenance of the production cell of 99m Tc is formed in the space portion Hosora medical diagnostic 99m Tc Recovery device.
JP2014143065A 2014-07-11 2014-07-11 99mTc recovery device for medical diagnosis Active JP6355462B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014143065A JP6355462B2 (en) 2014-07-11 2014-07-11 99mTc recovery device for medical diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014143065A JP6355462B2 (en) 2014-07-11 2014-07-11 99mTc recovery device for medical diagnosis

Publications (2)

Publication Number Publication Date
JP2016017935A JP2016017935A (en) 2016-02-01
JP6355462B2 true JP6355462B2 (en) 2018-07-11

Family

ID=55233235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014143065A Active JP6355462B2 (en) 2014-07-11 2014-07-11 99mTc recovery device for medical diagnosis

Country Status (1)

Country Link
JP (1) JP6355462B2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006039787A1 (en) * 2004-10-12 2006-04-20 Mcmaster University GENERATOR AND METHOD FOR PRODUCTION OF TECHNETIUM-99m
US7586102B2 (en) * 2006-08-14 2009-09-08 Board Of Regents The University Of Texas System Automated system for formulating radiopharmaceuticals
JP5427483B2 (en) * 2009-06-19 2014-02-26 株式会社化研 Concentration, elution recovery method, and system of radiotechnetium as a raw material for radiopharmaceuticals and their labeled compounds
JP5916082B2 (en) * 2011-12-23 2016-05-11 株式会社化研 99mTc recovery method and 99mTc recovery device
JP5916083B2 (en) * 2011-12-23 2016-05-11 株式会社化研 99mTc recovery device

Also Published As

Publication number Publication date
JP2016017935A (en) 2016-02-01

Similar Documents

Publication Publication Date Title
JP5427483B2 (en) Concentration, elution recovery method, and system of radiotechnetium as a raw material for radiopharmaceuticals and their labeled compounds
RU2548033C2 (en) Method and apparatus for extracting and processing molybdenum-99
JP4926546B2 (en) Method of using radiochemical solution synthesizer and radiochemical solution synthesizer
JP6478558B2 (en) Radiopharmaceutical manufacturing system, radiopharmaceutical manufacturing apparatus and radiopharmaceutical manufacturing method
AU2011264982A1 (en) Methods and apparatus for selective gaseous extraction of Molybdenum-99 and other fission product radioisotopes
US20220208409A1 (en) Radionuclide production method and radionuclide production system
AU2018201048B2 (en) A radioisotope concentrator and a process for capturing at least one radioisotope from a radioisotope solution
KR101586555B1 (en) The process and method for separation of useful radioisotopes in neutron irradiated target matrixes
JP5294180B2 (en) Method and apparatus for separating and purifying technetium from molybdenum containing technetium, and method and apparatus for recovering molybdenum
JP6355462B2 (en) 99mTc recovery device for medical diagnosis
JP5916082B2 (en) 99mTc recovery method and 99mTc recovery device
JP5916083B2 (en) 99mTc recovery device
JP4361537B2 (en) Maintenance method of radiochemical solution synthesizer and radiochemical solution synthesizer with cleaning function
WO2012039038A1 (en) Method for production/extraction of tc-99m utilizing mo-99, and mo-99/tc-99m liquid generator
JP2004028902A (en) Device for reducing amount of sodium sulfate and disposal system for radioactive ion exchange resin provided with the same
KR101725258B1 (en) High efficiency electrokinetic treatment method for uranium contaminated soil using the ion-exchange resins
CN106098128B (en) The hot cell system of radiopharmaceutical is repeatedly produced in short time
KR20210116302A (en) Salt Capable Of Selectively Hydrated With Tritium Water, Adsorbent That Binds To The Hydrate And Method For Removing Tritium Water Using The Same
Konior et al. Classic radionuclide 188W/188Re generator (experiments, design and construction)
JP2017178865A (en) Apparatus and method for manufacturing radioactive labeled compound
US20230411029A1 (en) Metal Ion Separation Technique Using pH Adjustment And Resin Packed Columns
Kochnov et al. Production of fission 99Mo at the VVR-Ts nuclear reactor in a closed-loop process with respect to U
JP5916084B2 (en) Purified Mo solution preparation method for preparation and purified Mo solution preparation apparatus for preparation
JP2018091708A (en) Technetium production device, technetium production method and radioactive medicine production method
US20050236331A1 (en) Sr-90/y-90 radionuclide generator for production of high-quality y-90 solution

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170315

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180426

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180605

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180612

R150 Certificate of patent or registration of utility model

Ref document number: 6355462

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250